期刊文献+

Eviendep~ reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouchanal anastomosis 被引量:2

Eviendep~ reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouchanal anastomosis
下载PDF
导出
摘要 AIM:To evaluate if 3 mo oral supplementation with Eviendep was able to reduce the number of duodenal polyps in familial adenomatous polyposis(FAP)patients with ileal pouch-anal anastomosis(IPAA).METHODS:Eleven FAP patients with IPAA and duodenal polyps were enrolled.They underwent upper gastrointestinal(GI)endoscopy at the baseline and after 3 mo of treatment.Each patient received 5 mg Eviendep twice a day,at breakfast and dinner time,for3 mo.Two endoscopists evaluated in a blinded manner the number and size of duodenal polyps.Upper GI endoscopies with biopsies were performed at the baseline(T0)with the assessment of the Spigelman score.Polyps>10 mm were removed during endoscopy and at the end of the procedure a new Spigelman score was determined(T1).The procedure was repeated 3 mo after the baseline(T2).Four photograms were examined for each patient,at T1 and T2.The examined area was divided into 3 segments:duodenal bulb,second and third portion duodenum.Biopsy specimens were taken from all polyps>10 mm and from all suspicious ones,defined by the presence of a central depression,irregular surface,or irregular vascular pattern.Histology was classified according to the updated Vienna criteria.RESULTS:At baseline the mean number of duodenal detected polyps was 27.7 and mean sizes were 15.8mm;the mean Spigelman score was 7.1.After polypectomy the mean number of duodenal detected polyps was 25.7 and mean sizes were 7.6 mm;the mean Spigelman score was 6.4.After 3 mo of Eviendep bid,all patients showed a reduction of number and size of duodenal polyps.The mean number of duodenal polyps was 8(P=0.021)and mean size was 4.4 mm;the mean Spigelman score was 6.6.Interrater agreement was measured.Lesions>1 cm found a very good degree of concordance(kappa 0.851)and a good concordance was as well encountered for smaller lesions(kappa 0.641).CONCLUSION:Our study demonstrated that shortterm(90 d)supplementation with Eviendep in FAP patients with IPAA and with recurrent adenomas in the duodenal mucosa,resulted effective in reducin AIM: To evaluate if 3 mo oral supplementation with Eviendep? was able to reduce the number of duodenal polyps in familial adenomatous polyposis (FAP) patients with ileal pouch-anal anastomosis (IPAA). METHODS: Eleven FAP patients with IPAA and duodenal polyps were enrolled. They underwent upper gastrointestinal (GI) endoscopy at the baseline and after 3 mo of treatment. Each patient received 5 mg Eviendep twice a day, at breakfast and dinner time, for 3 mo. Two endoscopists evaluated in a blinded manner the number and size of duodenal polyps. Upper GI endoscopies with biopsies were performed at the baseline (T0) with the assessment of the Spigelman score. Polyps > 10 mm were removed during endoscopy and at the end of the procedure a new Spigelman score was determined (T1). The procedure was repeated 3 mo after the baseline (T2). Four photograms were examined for each patient, at T1 and T2. The examined area was divided into 3 segments: duodenal bulb, second and third portion duodenum. Biopsy specimens were taken from all polyps > 10 mm and from all suspicious ones, defined by the presence of a central depression, irregular surface, or irregular vascular pattern. Histology was classified according to the updated Vienna criteria. RESULTS: At baseline the mean number of duodenal detected polyps was 27.7 and mean sizes were 15.8 mm; the mean Spigelman score was 7.1. After polypectomy the mean number of duodenal detected polyps was 25.7 and mean sizes were 7.6 mm; the mean Spigelman score was 6.4. After 3 mo of Eviendep bid, all patients showed a reduction of number and size of duodenal polyps. The mean number of duodenal polyps was 8 (P = 0.021) and mean size was 4.4 mm; the mean Spigelman score was 6.6. Interrater agreement was measured. Lesions > 1 cm found a very good degree of concordance (kappa 0.851) and a good concordance was as well encountered for smaller lesions (kappa 0.641). CONCLUSION: Our study demonstrated that short-term (90 d) supplementation with Eviendep? in FAP patients with IPAA and with recur
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第34期5671-5677,共7页 世界胃肠病学杂志(英文版)
关键词 Familial adenomatous POLYPOSIS ILEAL pouch-anal ANASTOMOSIS DUODENAL POLYPS Eviendep Familial adenomatous polyposis Ileal pouch-anal anastomosis Duodenal polyps Eviendep
  • 相关文献

参考文献21

  • 1Mariabeatrice Principi,Alfredo Di Leo,Maria Pricci,Maria Principia Scavo,Raffaella Guido,Sabina Tanzi,Domenico Piscitelli,Antonio Pisani,Enzo Ierardi,Maria Cristina Comelli,Michele Barone.phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study[J].World Journal of Gastroenterology,2013,19(27):4325-4333. 被引量:3
  • 2S. Bülow,I. J. Christensen,H. H?jen,J. Bj?rk,M. Elmberg,H. J?rvinen,A. Lepist?,M. Nieuwenhuis,H. Vasen.Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis[J].Colorectal Disease.2012(8) 被引量:1
  • 3Brian Kim,Francis M. Giardiello.Chemoprevention in familial adenomatous polyposis[J].Best Practice & Research Clinical Gastroenterology.2011(4) 被引量:1
  • 4Andrew R. Latchford,Kay F. Neale,Allan D. Spigelman,Robin K.S. Phillips,Susan K. Clark.Features of Duodenal Cancer in Patients With Familial Adenomatous Polyposis[J].Clinical Gastroenterology and Hepatology.2009(6) 被引量:1
  • 5A. Langers,W. De Vos tot Nederveen Cappel,R. Veenendaal,B. Bonsing,J. Hardwick,H. Vasen.Double balloon endoscopy for detection of small-bowel adenomas in familial adenomatous polyposis after pancreaticoduodenectomy according to Whipple[J].Endoscopy.2008(09) 被引量:1
  • 6Rory Kennelly,Dara O Kavanagh,Aisling M Hogan,Desmond C Winter.Oestrogen and the colon: potential mechanisms for cancer prevention[J].Lancet Oncology.2008(4) 被引量:1
  • 7Gaetano Iaquinto,Mara Fornasarig,Michele Quaia,Nicola Giardullo,Vittorio D’Onofrio,Salvatore Iaquinto,Simone Di Bella,Renato Cannizzaro.Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis[J].Gastrointestinal Endoscopy.2008(1) 被引量:1
  • 8K. M?nkemüller,L. Fry,M. Ebert,M. Bellutti,M. Venerito,C. Knippig,S. Rickes,P. Muschke,C. R?cken,P. Malfertheiner.Feasibility of double-balloon enteroscopy-assisted chromoendoscopy of the small bowel in patients with familial adenomatous polyposis[J].Endoscopy.2007(01) 被引量:1
  • 9A. Di Leo,M. Barone,M. Margiotta,A. Castellaneta,L. Troiani,L. Demarinis,S. Tanzi,R. Guido,A. Francavilla.Effect of a selective agonist for the estrogen receptor β (Silymarin) upon colonic cell migration in normal mice[J].Digestive and Liver Disease.2006 被引量:1
  • 10D Seidlová-Wuttke,T Becker,V Christoffel,H Jarry,W Wuttke.Silymarin is a selective estrogen receptor β (ERβ) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats[J].Journal of Steroid Biochemistry and Molecular Biology.2003(2) 被引量:1

二级参考文献10

  • 1M Barone,MP Scavo,S Papagni,D Piscitelli,R Guido,M Lena,MC Comelli,A Leo.Erβ expression in normal adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis[].Scandinavian Journal of Gastroenterology.2010 被引量:1
  • 2Volate SR,Davenport DM,Muga SJ,Wargovich MJ.Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin)[].Carcinogenesis.2005 被引量:1
  • 3Konstantinopoulos PA,Kominea A,Vandoros G,et al.Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation[].European Journal of Cancer.2003 被引量:1
  • 4Campbell-Thompson M,Lynch IJ,Bhardwaj B.Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer[].Cancer Research.2001 被引量:1
  • 5Di Leo A,Messa C,Cavallini A,et al.Estrogens and colorectal cancer[].Current Drug Targets Immune Endocrine and Metabolic Disorders.2001 被引量:1
  • 6Nawaz Z,Lonard D M,Dennis A P,et al.Proteasome-dependent degradation of the human estrogen receptor[].Proceedings of the National Academy of Sciences of the United States of America.1999 被引量:1
  • 7Landis J R,Koch G G.The measurement of observer agreement for categorical data[].Biometrics.1977 被引量:1
  • 8Francavilla,A,Di,Leo,A,Polimeno,L,Conte,D,Barone,M,Fanizza,G,Chiumarulo,C,Rizzo,G,Rubino,M.Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous clonic tissue[].Gastroenterology.1987 被引量:1
  • 9Chunyan Zhao,Karin Dahlman Wright,Jan-Ake Gustafsson.Estrogen recap-tor β:an overview and update[].Nuclear Receptor Signaling.2008 被引量:1
  • 10Woodson,K,Lanza,E,Tangrea,JA,Albert,PS,Slattery,M,Pinsky,J,Caan,B,Paskett,E,Iber,F,Kikendall,JW,Lance,P,Shike,M,Weissfeld,J,Schatzkin,A.Hormone replacement therapy and colorectal adenoma recurrence among women in the polyp prevention trial[].Report J Natl Cancer Inst.2001 被引量:1

共引文献2

同被引文献56

  • 1Nynne Nyboe Andersen,Tine Jess.Has the risk of colorectal cancer in inflammatory bowel disease decreased?[J].World Journal of Gastroenterology,2013,19(43):7561-7568. 被引量:7
  • 2Martina Galatola,Erasmo Miele,Caterina Strisciuglio,Lorella Paparo,Daniela Rega,Paolo Delrio,Francesca Duraturo,Massimo Martinelli,Giovanni Battista Rossi,Annamaria Staiano,Paola Izzo,Marina De Rosa.Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis[J].World Journal of Gastroenterology,2013,19(46):8659-8670. 被引量:7
  • 3Mariabeatrice Principi,Alfredo Di Leo,Maria Pricci,Maria Principia Scavo,Raffaella Guido,Sabina Tanzi,Domenico Piscitelli,Antonio Pisani,Enzo Ierardi,Maria Cristina Comelli,Michele Barone.phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study[J].World Journal of Gastroenterology,2013,19(27):4325-4333. 被引量:3
  • 4Noam Harpaz,Stephen C. Ward,Claudia Mescoli,Steven H. Itzkowitz,Alexandros D. Polydorides.Precancerous lesions in inflammatory bowel disease[J].Best Practice & Research Clinical Gastroenterology.2013(2) 被引量:3
  • 5Tine Jess,Christine Rungoe,Laurent Peyrin–Biroulet.Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies[J].Clinical Gastroenterology and Hepatology.2012(6) 被引量:11
  • 6J. E. Baars,E. J. Kuipers,M. Haastert,J. J. Nicola?,A. C. Poen,C. J. Woude.Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey[J].Journal of Gastroenterology.2012(12) 被引量:2
  • 7Tine Jess,Jacob Simonsen,Kristian Tore J?rgensen,Bo Vestergaard Pedersen,Nete Munk Nielsen,Morten Frisch.Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years[J].Gastroenterology.2012(2) 被引量:4
  • 8F. Magro,C. Langner,A. Driessen,A. Ensari,K. Geboes,G.J. Mantzaris,V. Villanacci,G. Becheanu,P. Borralho Nunes,G. Cathomas,W. Fries,A. Jouret-Mourin,C. Mescoli,G. de Petris,C.A. Rubio,N.A. Shepherd,M. Vieth,R. Eliakim.European consensus on the histopathology of inflammatory bowel disease[J].Journal of Crohn’s and Colitis.2013 被引量:2
  • 9Vito Annese,Marco Daperno,Matthew D. Rutter,Aurelien Amiot,Peter Bossuyt,James East,Marc Ferrante,Martin G?tz,Konstantinos H. Katsanos,Ralf Kie?lich,Ingrid Ordás,Alessandro Repici,Bruno Rosa,Shaji Sebastian,Torsten Kucharzik,Rami Eliakim.European evidence based consensus for endoscopy in inflammatory bowel disease[J].Journal of Crohn’s and Colitis.2013(12) 被引量:7
  • 10M. Principi,M.P. Scavo,D. Piscitelli,V. Villanacci,A. Contaldo,V. Neve,K. Lofano,G. Piacentino,N. De Tullio,E. Ierardi,A. Di Leo.P013 The fall of estrogen receptors expression in long-lasting ulcerative-associated carcinoma[J].Journal of Crohn’s and Colitis.2013 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部